Emmaus Life Sciences Inc (QB) (EMMA)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current EMMA market cap is 957.98k. The company's latest EPS is USD -0.1010 and P/E is -27.43.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 23.17M | 20.61M | 18.39M | 29.6M | 16.65M |
| Operating Income | -2.35M | -8.86M | -8.5M | 1.83M | -1.89M |
| Net Income | 1.1M | -15.95M | -10.63M | -3.73M | -6.45M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.28M | 56.73M | 48.23M | 35.18M | 23.6M |
| Total Liabilities | 64.69M | 78.18M | 82.32M | 82.94M | 80.08M |
| Total Equity | -5.42M | -21.45M | -34.09M | -47.76M | -56.48M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.45M | -1.25M | -5.07M | -1.5M | -2.29M |
| Investing | 5.47M | -6.38M | -2.39M | -432k | 2.5M |
| Financing | -2.31M | 7.41M | 7.23M | 2.48M | -1.35M |
| Market Cap | 957.98k |
| Price to Earnings Ratio | -27.43 |
| Price to Sales Ratio | 10.62 |
| Price to Cash Ratio | 127.65 |
| Price to Book Ratio | -3.13 |
| Dividend Yield | - |
| Shares Outstanding | 63.87M |
| Average Volume (1 week) | 35.27k |
| Average Volume (1 Month) | 27.31k |
| 52 Week Change | -83.52% |
| 52 Week High | 0.10115 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0 (3.33%) |
| Company Name | Emmaus Life Sciences Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.emmausmedical.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
